Cardioloxía
St George's, University of London
Londres, Reino UnidoPublications in collaboration with researchers from St George's, University of London (19)
2023
-
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial
International Journal of Cardiology, Vol. 391
2022
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
2021
2019
-
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry
JAMA Cardiology, Vol. 4, Núm. 6, pp. 526-548
-
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
Thrombosis Journal, Vol. 17, Núm. 1
-
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry
Journal of the American Heart Association, Vol. 8, Núm. 3
-
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
American Heart Journal, Vol. 213, pp. 35-46
2018
-
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry
European Heart Journal, Vol. 39, Núm. 6, pp. 464-473
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835
2017
-
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Heart, Vol. 103, Núm. 4, pp. 307-314
-
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry
BMJ Open, Vol. 7, Núm. 3
-
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
BMJ Open, Vol. 7, Núm. 12
2016
-
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry
PLoS ONE, Vol. 11, Núm. 10
-
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
European Heart Journal, Vol. 37, Núm. 38, pp. 2882-2889
2015
-
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation
Circulation: Cardiovascular Quality and Outcomes, Vol. 8, pp. S12-S20
2010
-
A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study
Atherosclerosis, Vol. 212, Núm. 2, pp. 636-643
2008
-
Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome
Atherosclerosis, Vol. 201, Núm. 1, pp. 176-183
2003
-
Marcadores de inflamación y estratificacin de riesgo en pacientes con síndrome coronario agudo: Diseño del estudio SIESTA (Sytemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndromes)
Revista Espanola de Cardiologia, Vol. 56, Núm. 4, pp. 389-395